Inmune Bio (INMB) Research & Development (2018 - 2026)
Inmune Bio's Research & Development came in at -$803,000 for Q2 2026, compared with $5.8 million a year earlier.
Powered by 
Analysis
Inmune Bio (INMB) Research & Development (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Inmune Bio reported Research & Development of $10.05 million, down 67.4% year-over-year; for FY2025, it was $20.66 million, down 37.7% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
- Going back by year, Research & Development was $33.17 million in FY2024 (+63.6%), $20.27 million in FY2023 (+18.8%), $17.07 million in FY2022 (-16.9%) and $20.54 million in FY2021 (+247.1%).
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q1 2018.
- Year-over-year, Research & Development increased in two of the last seven quarters, with an average decline of 15.9%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 280.2%), and the weakest in Q4 2025 (a decline of 68.3%).
- Business Quant data shows INMB's Research & Development at $3.64 million (Q1 2026), $2.33 million (Q4 2025) and $4.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Inmune Bio | 55.31 Mn | -36.95 Mn | - | -803,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -803,000.00 |
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 5.80 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Sep 30, 2024 | 10.07 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Mar 31, 2024 | 8.69 Mn |
| Dec 31, 2023 | 6.01 Mn |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 5.16 Mn |
| Jun 30, 2022 | 4.19 Mn |
| Mar 31, 2022 | 4.31 Mn |
| Dec 31, 2021 | 7.07 Mn |
| Sep 30, 2021 | 6.52 Mn |
API Access
Inmune Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();